[HTML][HTML] Pro-inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: biomarkers of SARS-CoV-2 infection
AS Tripathy, S Vishwakarma, D Trimbake, YK Gurav… - Archives of …, 2021 - Springer
Currently, the world is witnessing the pandemic of COVID-19, a disease caused by the novel
coronavirus SARS-CoV-2. Reported differences in clinical manifestations and outcomes in …
coronavirus SARS-CoV-2. Reported differences in clinical manifestations and outcomes in …
Pro-inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: biomarkers of SARS-CoV-2 infection.
AS Tripathy, S Vishwakarma, D Trimbake… - Archives of …, 2021 - search.ebscohost.com
Currently, the world is witnessing the pandemic of COVID-19, a disease caused by the novel
coronavirus SARS-CoV-2. Reported differences in clinical manifestations and outcomes in …
coronavirus SARS-CoV-2. Reported differences in clinical manifestations and outcomes in …
[PDF][PDF] Pro‑inflammatory CXCL‑10, TNF‑α, IL‑1β, and IL‑6: biomarkers of SARS‑CoV‑2 infection
AS Tripathy, S Vishwakarma, D Trimbake… - Archives of …, 2021 - researchgate.net
Currently, the world is witnessing the pandemic of COVID-19, a disease caused by the novel
coronavirus SARS-CoV-2. Reported differences in clinical manifestations and outcomes in …
coronavirus SARS-CoV-2. Reported differences in clinical manifestations and outcomes in …
Pro-inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: biomarkers of SARS-CoV-2 infection.
AS Tripathy, S Vishwakarma, D Trimbake… - Archives of …, 2021 - europepmc.org
Currently, the world is witnessing the pandemic of COVID-19, a disease caused by the novel
coronavirus SARS-CoV-2. Reported differences in clinical manifestations and outcomes in …
coronavirus SARS-CoV-2. Reported differences in clinical manifestations and outcomes in …
Pro-inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: biomarkers of SARS-CoV-2 infection
AS Tripathy, V Siddhesh, T Diptee… - Archives of …, 2021 - search.proquest.com
Currently, the world is witnessing the pandemic of COVID-19, a disease caused by the novel
coronavirus SARS-CoV-2. Reported differences in clinical manifestations and outcomes in …
coronavirus SARS-CoV-2. Reported differences in clinical manifestations and outcomes in …
Pro-inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: biomarkers of SARS-CoV-2 infection
AS Tripathy, S Vishwakarma, D Trimbake… - Archives of …, 2021 - pubmed.ncbi.nlm.nih.gov
Currently, the world is witnessing the pandemic of COVID-19, a disease caused by the novel
coronavirus SARS-CoV-2. Reported differences in clinical manifestations and outcomes in …
coronavirus SARS-CoV-2. Reported differences in clinical manifestations and outcomes in …
[HTML][HTML] Pro-inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: biomarkers of SARS-CoV-2 infection
AS Tripathy, S Vishwakarma, D Trimbake… - Archives of …, 2021 - ncbi.nlm.nih.gov
Currently, the world is witnessing the pandemic of COVID-19, a disease caused by the novel
coronavirus SARS-CoV-2. Reported differences in clinical manifestations and outcomes in …
coronavirus SARS-CoV-2. Reported differences in clinical manifestations and outcomes in …
Pro-inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: biomarkers of SARS-CoV-2 infection.
AS Tripathy, S Vishwakarma, D Trimbake, YK Gurav… - 2021 - cabidigitallibrary.org
Currently, the world is witnessing the pandemic of COVID-19, a disease caused by the novel
coronavirus SARS-CoV-2. Reported differences in clinical manifestations and outcomes in …
coronavirus SARS-CoV-2. Reported differences in clinical manifestations and outcomes in …